LUME-Meso Trial Pemetrexed, Cisplatin and Nintedanib Superior PFS
Anne S. Tsao, MD of MD Anderson Cancer Center discusses the LUME-Meso Trial using Pemetrexed, Cisplatin and Nintedanib demonstrates superior PFS from the 22nd Annual Perspectives in Thoracic Oncology ...
Author: thoraciconcology
Added: 12/29/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts